It wasn’t long ago that General Electric Co. GE was one of the largest blue chip industrial stocks in the U.S.
On Wednesday, one Wall Street analyst said that once GE divests its oil and gas, health care and transportation businesses, the remaining company may have little or no value.
The Analyst
Gordon Haskett analyst John Inch reiterated an Underperform rating on GE with a $7 price target.
The Thesis
The asset sales may be good news for GE’s liquidity problems in the near-term, but will also eliminate all of the company’s main cash-generating businesses, Inch said in a note.
Investors can expect proceeds of between $71 billion and $80 billion from GE’s upcoming asset sales, the analyst said.
GE privately filed paperwork for a GE Healthcare IPO in December. CNBC reported that the IPO will likely come sometime in mid-2019.
Even after subtracting those projected proceeds from Inch’s estimates for GE’s remaining on- and off-balance sheet liabilities, the analyst estimates the remaining company will still have between $144 billion and $203 billion in liabilities and only about $70 billion to $78 billion in industrial assets.
“After combining with GE Capital assets of $111-129 billion and aforementioned total company remaining debt plus other liabilities, this results in a market value for GE equity of [negative] $2.47 to just over $7/share, or a midpoint of just over $2/GE share."
It may be prudent for GE to raise equity capital to shore up its balance sheet, Inch said, adding that the process would understandably be difficult and dilutive given GE’s share price.
Price Action
GE stock was trading up 0.75 percent at $8.78 at the time of publication Thursday and is now down about 69 percent in the last three years.
Related Links:
What's Next For General Electric's Stock? Here's A Technical Take
Photo by Jud McCranie/Wikimedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.